This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Results: There were no significant differences in fertilization, survival, or blastocyst development rates between the two insemination treatment groups. However, for women >35 years of age, the fertilization (P = .008) and blastocyst development (P = .016) rates with Piezo-ICSI on D5 and D6 were significantly higher than in those subjected to c-ICSI.
| INTRODUC TI ON
Although intracytoplasmic sperm injection (ICSI) has been largely restricted to patients showing repeated failure of in vitro fertilization (IVF), ICSI is widely recognized as a major technique in assisted reproductive technology (ART).
1 When conventional ICSI (c-ICSI) is performed, the injection needle penetrates the zona pellucida and then perforates the oolemma. Oocyte cytoplasm is then aspirated into the injection needle to rupture the oolemma, followed by injection of a spermatozoon. 
| MATERIAL S AND ME THODS

| Study population
From October to December 2017, 137 patients with 1356 oocytes were studied at Hanabusa Women's Clinic (Table 1) . Patients were stimulated with a standard superovulation protocol (see below), and oocytes from cycles with more than two retrieved mature oocytes were used in this study. As a result, 947 mature oocytes were studied:
Half of the oocytes from each patient were inseminated using c-ICSI and the remaining sibling oocytes were subjected to Piezo-ICSI. This study was approved by the Institutional Review Board of Hanabusa Women's Clinic (IRB number Hanabusa Women's Clinic #07).
| Oocyte retrieval, sperm preparation, and culture conditions
All patients were stimulated to super-ovulate with a standard long protocol, a short protocol, or a gonadotropin-releasing hormone (GnRH) agonist protocol, and clomiphene citrate or letrozole was administered to patients who showed a poor response to these standard protocols. Details of patients, anti-Mullerian hormone (AMH), basal follicle-stimulating hormone (FSH), and ovarian stimulation methods are shown in Table 1 .
Spermatozoa were prepared from the partner's semen using two-layer Percoll density gradients. Normal-appearing spermatozoa were inseminated into oocytes, and then, zygotes and embryos were cultured in SAGE 1
Step Medium (Origio) under a humidified gas mixture of 5.5% CO 2 , 5% O 2 and 89.5% N 2 at 37°C.
| Sperm preparation
Collected semen samples were centrifuged using two Percoll solutions 
| Conventional ICSI
The c-ICSI procedure was conducted using an Olympus inverted microscope (Olympus IX-73) equipped with a micromanipulator system (TAKANOME ® MTK-1-03; NARISHIGE). Morphologically normal spermatozoa were immobilized in polyvinylpyrrolidone (7% PVP solution; Fujifilm Irvine Scientific) using an injection needle (K-MPIP-3130 Cook Medical), and oocytes were held by holding pipette (Kitazato Corporation) with the first polar body at twelve or 6 o'clock, and then, the injection needle was inserted at 3 o'clock and a single spermatozoon was injected after the first aspirating some ooplasm to break the oolemma.
| Piezo-ICSI
Piezo-ICSI was performed using ultrathin injection needles (PINU06-20FT:
Prime Tech Ltd.) that had a flat-tip with 6 μm outer diameter and 5.1 μm inner diameter, as described by Hiraoka et al 5 Twelve microlitres of operating liquid was drawn into the center of the injection pipette. The TA B L E 1 Background of patients and ovarian stimulation protocols used before oocyte retrieval
Characteristics Value
No. of patients 137
Age at ICSI (y) Piezo-assisted equipment used in this study was PIEZO PMM4G (Prime Tech Ltd.) equipped with a micromanipulator system (TAKANOME ® MTK-1-03, NARISHIGE, Tokyo, Japan; Figure 1 ). The oocyte was restrained by the pipette, but the orientation of the first polar body was not considered when inserting the needle into the widely opened perivitelline space. Piezo pulses were generated with a speed setting of 2.0 and an intensity setting of 2.0 to penetrate the zona pellucida at three o'clock. An immobilized spermatozoon was aspirated then moved to the tip of the needle, which was inserted into the middle of the cytoplasm. The plasma membrane was punctured using a Piezo pulse (speed setting 2.0; intensity setting 1.0), and the spermatozoon was injected into the oocyte from the head. Cytoplasm was not aspirated into the injection needle.
| Evaluation of data
Fertilization rate (%) (2PN, 1PN, and 3PN ), oocyte survival rate (%), and blastocyst formation per continuing pregnancy at day 5 or day 6 (%) were evaluated. Data were analyzed according to the age of women. Terms "aged" and "non-aged" were defined as women >35
or ≤35 years old, respectively, according to several reports which defined 35 years old as the border line of aged and non-aged women.
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| Morphological evaluation of cleaved embryos and blastocysts
Evaluation of blastocysts on D5 or D6 was performed according to the classification of Gardner and Schoolcraft 9 and better than Grade 3BB embryos were designated good-quality blastocysts.
| Data analysis
Statistical analysis for numerical data was done using non-paired Student's t tests after the uniformity of dispersion was examined, and non-numerical data were evaluated using chi-squared tests.
Statistical significance was set at P < .05.
| RE SULTS
The mean age of all patients was 37. (Table 3) . By contrast, for women aged >35 years, the fertilization rates of c-ICSI and Piezo-ICSI were 64.3% (171/266) and 74.8%
(202/270) with a significant difference between treatments (P = .008).
Oocyte survival rates of c-ICSI and Piezo-ICSI were 92.5% (246/266) and 94.1% (254/270), respectively, with no significant difference between the two groups. The blastocyst development rates on D5/D6 were significantly lower in the c-ICSI group (39.6%, 67/169) vs the Piezo-ICSI group (52.4%, 100/191) for women aged >35 years (P = .016; Table 4 ). As shown in Table 5 , there were no significant differences in pregnancy rates 
| D ISCUSS I ON
In this study, Piezo-assisted ICSI improved the fertilization and D5/D6 blastocyst development rates significantly in women aged >35 years old when it was compared with c-ICSI. However, there were no statistically significant differences in any evaluated parameters when considering the whole patient group or the ≤35 years of age subgroup between Piezo-ICSI and c-ICSI, while a fertilization rate with 1PN in whole patients of Piezo-ICSI group was significant lower than c-ICSI group. This might be due to solid execution of penetrating oolemma by Piezo-ICSI. Piezo-ICSI is a technique that improves the fertilization rate of mouse, rabbit, equine, and bovine oocytes. It was reported to be more efficient than the c-ICSI method for fertilizing and obtaining more bovine embryos. 10 In horses, Piezo-ICSI was associated with more rapid sperm component remodeling and meiotic resumption in the oocyte than c-ICSI and produced better quality blastocyst stage embryos. 11 The plasma membrane of the mouse oocyte has high extendibility, and the ooplasm has low viscosity, and these factors lead to survival rates of <50% following c-ICSI. 12 In contrast, Piezo-ICSI can reduce damage to the oocyte's plasma membrane and achieve nearly 100% survival rates and high blastocyst development rates. For these reasons, Piezo-ICSI is considered highly effective for species exhibiting oocytes with delicate plasma membranes. 13, 14 Similar to our results, c-ICSI was reported to have a higher oocyte degeneration ratio than Piezo-ICSI for human oocytes. 4 Hiraoka and Kitamura reported that Piezo-ICSI using an ultrathin needle could markedly reduce the size of the ruptured area in the oocyte's plasma membrane and improve oocyte survival and fertilization rates without detrimental effects on embryo development or implantation ability when compared with c-ICSI.
5
It is widely accepted that both the quantity and quality of oocytes decline with a woman's age, leading to a lower success rate in ART. 15 Several theories have been proposed to explain the decline in oocyte quality with age. The so-called "production line hypothesis" postulates that oocytes less susceptible to chromosomal non-disjunction are ovulated first, leaving poor quality oocytes to be ovulated later in life. 16 However, this hypothesis does not explain why the order of oocyte differentiation induces the postulated differences in recombination frequency. Another theory invokes the age-related accumulation of damage from several mechanisms including oxidative stress, elevated FSH levels, and mitochondrial dysfunction. [17] [18] [19] Our results indicate that changes in oocyte cell membrane viscosity may also be related to the woman's age. Finally, our findings suggest that Piezo-ICSI is particularly effective for patients aged >35 years undergoing ART, as Piezo-ICSI is less invasive to oocytes of aged women compared with c-ICSI.
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